Contact this trialFirst, we need to learn more about you.
Gene Therapy
Gene Therapy for Chronic Granulomatous Disease
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial involves taking a patient's own stem cells, correcting a genetic defect in a lab, and then reintroducing these modified cells back into the patient. It targets individuals with Chronic Granulomatous Disease (CGD), a condition where white blood cells can't effectively fight infections. The treatment uses a method to insert a healthy gene into the patient's stem cells, enabling them to produce functional white blood cells. Gene therapy has shown promise in treating Chronic Granulomatous Disease (CGD) by using corrected stem cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service